Seres Therapeutics
MCRB
#8981
Rank
C$0.13 B
Marketcap
$0.78
Share price
-3.90%
Change (1 day)
-21.59%
Change (1 year)

EPS for Seres Therapeutics (MCRB)

EPS in 2023 (TTM): -$1.53

According to Seres Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.59. In 2022 the company made an earnings per share (EPS) of -$3.31 a decrease over its 2021 EPS that were of -$1.03.

EPS history for Seres Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.53-53.83%
2022-$3.31220.55%
2021-$1.03-34.23%
2020-$1.57-15.27%
2019-$1.85-46.09%
2018-$3.449.95%
2017-$3.13-3.49%
2016-$3.24-10.19%
2015-$3.61321.85%
2014-$0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.03 91.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.59 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA